:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/5F33CZVKQRGIJIFRLNFB7CTCQE.jpg)
Vacunación. El 99% de los mayores desarrolla anticuerpos tras la inmunización completa con Pfizer
Cerca del 70% tiene sintomas leves o ninguno tras la segunda dosis, según una investigación pionera con cerca de 900 ancianos de residencias de la Comunidad Valenciana.
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/HK3GVVTBBZDVBA3A7FR2IA4QXQ.jpg)
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/Z5BBZWLP7FCDBBHMEMNO2MIQRU.jpg)
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/YODM72CQG5FFBJX4W3JY26XV4E.jpg)
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/2HJ2MLDXPRHRNMFV322HN7JU7I.jpg)
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/4UBBZSX6QBFKHPICCUS5H36S4M.jpg)
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/3X2K6VGSQ5H3HEGKARE72OLF7Y.jpg)
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/MFRWO5QS7VG47DSMVGEBYUWKMM.jpg)
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/6AUA7IZGBVEVVJCC6AEQ6CYAOU.jpg)
:format(webp):quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/RQ2HTNM675DHHP5QBB2JNTT23U.JPG)
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/RH43UMB3VFGEVCLRAKPJEETH4A.JPG)
:quality(65)/cloudfront-eu-central-1.images.arcpublishing.com/larazon/JWJF7P74WBBLRBXMUEOSEEFEUU.JPG)